About Indee

Indee is an early stage biotechnology company developing a new method and device for delivering therapeutically relevant molecules into cells.

This device is aimed at addressing the current unmet need in clinical and commercial scale manufacturing for affordable and scalable cell-based therapies.

Indee was founded on the idea that everyone should be able to access safe, effective, and affordable cell-based therapies. We believe our patent pending platform technology will reduce the manufacturing costs and extend the accessibility of life-saving cell therapies.

More information


  • Ryan Pawell PhD, CEO
  • Matthew Burhardt, CSO

Find out more: